Syndrome News and Research

RSS

Reitman Foundation funds pilot study to investigate outcomes of neonates treated for opioid withdrawal

Researchers at Kessler Foundation will collaborate with Children's Specialized Hospital to study the outcomes of neonates treated for opioid withdrawal in the Hospital's Neonatal Abstinence Syndrome Program.

3 Mar 2020

NHS doctors say UK not prepared for coronavirus outbreak

The coronavirus disease (COVID-19) outbreak has spread dramatically around the globe, infecting more than 92,000 people and killing more than 3,000.

3 Mar 2020

The changing face of the COVID-19 epidemic

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus, which hit China with the disease now named COVID-19 in December 2019 and has since spread to over 70 countries, has caused over 90,000 cases, and 3,117 fatalities, with 95% or more of both being in China.

2 Mar 2020

Study reveals the neural basis of sensory hypersensitivity in people with autism

Many people with autism spectrum disorders are highly sensitive to light, noise, and other sensory input. A new study in mice reveals a neural circuit that appears to underlie this hypersensitivity, offering a possible strategy for developing new treatments.

2 Mar 2020

UK races to tackle coronavirus spread

The coronavirus disease (COVID-19) outbreak spiked dramatically on Sunday, with more countries reporting additional cases. The deadly virus has added 13 more confirmed cases in the United Kingdom, with Scotland reporting its first case. Health officials are racing to identify people who are unaware they may have been exposed.

1 Mar 2020

New inhalation therapy could relieve lung fibrosis in mice and rats

A new study published in the journal Nature Communications in February 2020 shows that secretions from stem cells in the lung can be utilized to nebulize injured lungs due to several types of lung fibrosis in rats and mice. This could well result in the development of less invasive and more effective therapies for lung fibrosis.

1 Mar 2020

Drug for Ebola and MERS effective against COVID-19

A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.

1 Mar 2020

New research cluster aims to use mass spectrometry to provide insights in systems medicine

The Mainz University Medical Center and Johannes Gutenberg University Mainz are establishing the interdisciplinary research cluster entitled "Data-Independent Acquisition-based Systems Medicine (DIASyM): Mass Spectrometry for High-Throughput Deep Phenotyping of Heart Failure Syndrome".

28 Feb 2020

Researchers show how investigational antiviral drug stops coronavirus

A team of academic and industry researchers is reporting new findings about how exactly an investigational antiviral drug stops coronaviruses.

28 Feb 2020

New studies explore risk factors and public health concerns over coronavirus

Emergency physician-led teams are on the frontlines of coronavirus treatment, prevention and response. JACEP Open, a new official open access journal of the American College of Emergency Physicians (ACEP), explores coronavirus (COVID-19) concerns in two new analyses.

28 Feb 2020

New imaging method allows scientists to view key part of the colon in 3D

In a groundbreaking discovery, researchers at Children's Hospital of Philadelphia developed a new imaging method that allows scientists to view the enteric nervous system - a key part of the human colon - in three dimensions by making other colon cells that normally block it invisible.

27 Feb 2020

Eating less prolongs life

A new study published in the journal Cell in February 2020 reports that eating less is associated with better immunity, reduce inflammation all over the body, and reduced odds of diseases related to old age, as well as increasing the odds of living longer.

27 Feb 2020

Cancer chemical from common gut microbe

Many common gut bacteria carry cancer-causing mutations, says a new study published in the journal Nature on the 27th February 2020.

27 Feb 2020

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

A new, phase I clinical trial offered The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute will treat patients with relapsed or refractory acute myeloid leukemia using a novel universal natural killer cell approach.

27 Feb 2020

KHN’s ‘What the Health?’: Prepping for a possible pandemic

President Donald Trump has named Vice President Mike Pence to lead the nation's effort to combat COVID-19, the contagious disease from a coronavirus that originated in China and is spreading worldwide.

27 Feb 2020

New compounds may help stop the spread of the coronavirus

Amid the global health crisis of the coronavirus (COVID-19), scientists from around the world are racing to find a treatment to stop the deadly virus. The sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across 46 countries, infecting more than 82,000 and killing more than 2,800 people.

26 Feb 2020

Mount Sinai physicians first in the U.S. to analyze chest CT scans of patients with COVID-19

Mount Sinai Health System physicians--the first experts in the country to analyze chest computed tomography (CT) scans of patients from China with coronavirus disease (COVID-19)--have identified specific patterns in the lungs as markers of the disease as it develops over the course of a week and a half.

26 Feb 2020

Study contributes to better understanding of rare KAT6A syndrome

A research team has described five new cases of a rare disease -known as KAT6A syndrome- of which there are only eighty dominant cases worldwide.

26 Feb 2020

HKUST scientists provide leads for guiding research towards COVID-19 vaccine development

A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.

26 Feb 2020

Clinical trial to evaluate safety, efficacy of remdesivir in adults with COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.

25 Feb 2020